properti
neutral
antigen
canin
distemp
viru
onderstepoort
recent
field
isol
investig
strainspecif
dog
sera
convent
neutral
assay
indic
antigen
dissimilar
strain
howev
guinea
pig
complement
includ
reaction
mixtur
strain
neutral
homolog
also
heterolog
antibodi
canin
distemp
viru
cdv
member
morbilliviru
genu
paramyxovirida
famili
diseas
caus
cdv
one
import
viral
infect
puppi
cdv
first
cultiv
cell
attenu
vaccin
virus
adopt
modifi
live
viru
mlv
vaccin
product
current
avail
mlv
cdv
vaccin
though
manufactur
use
strain
onderstepoort
osp
rockborn
snyder
hill
isol
refer
old
cdv
previous
describ
us
well
other
recent
field
cdv
refer
new
cdv
variou
part
world
possess
differ
hemagglutinin
h
gene
protein
characterist
addit
antigen
heterogen
new
old
cdv
also
demonstr
previous
use
either
monoclon
polyclon
immun
sera
observ
make
clinic
import
elucid
antigen
variat
humor
immun
total
explain
resist
canin
distemp
practic
monitor
routin
cellmedi
immun
statu
dog
thu
level
natur
antibodi
cdv
util
valuabl
altern
indic
assess
vaccin
efficaci
immun
statu
anim
correl
protect
cdv
howev
antigen
genet
variat
h
protein
differ
new
cdv
strain
new
old
strain
may
rais
doubt
efficaci
present
vaccin
product
ideal
approach
demonstr
vaccin
efficaci
perform
challeng
studi
vivo
howev
well
known
experiment
reproduc
clinic
canin
distemp
hard
achiev
knowledg
one
author
challeng
system
adopt
worldwid
intracrani
challeng
exposur
dogpassag
virul
snyder
hill
strain
belong
phylogenet
old
cdv
fig
context
neutral
antigen
relationship
osp
new
cdv
strain
belong
genotyp
investig
virus
cultiv
vero
cell
cultur
fluid
passag
use
inocul
puppi
plaqu
reduct
neutral
test
prnt
respect
vero
cell
cultiv
gener
cell
cultur
techniqu
eagl
minim
essenti
medium
mem
supplement
fetal
calf
serum
antibiot
dog
sera
dilut
time
eagl
mem
heat
inactiv
min
antibodi
titer
examin
prnt
prnt
perform
gener
method
briefli
follow
reaction
mixtur
consist
l
serum
dilut
l
eagl
mem
guinea
pig
complement
dilut
l
viru
fluid
contain
approxim
pfu
plate
iwaki
glass
tokyo
japan
guinea
pig
complement
obtain
icn
pharmaceut
inc
catalog
dilut
volvol
eagl
mem
use
reaction
mixtur
incub
h
l
mixtur
inocul
onto
vero
cell
cultur
sixwel
plate
iwaki
glass
h
incub
viru
adsorpt
inoculum
aspir
overlay
medium
ad
cell
sheet
overlay
medium
eagl
mem
contain
wtvol
nobl
agar
fetal
calf
serum
antibiot
prnt
osp
plate
incub
day
cell
stain
neutral
red
plaqu
count
case
plate
incub
day
medium
addit
overlaid
add
nutrient
incub
day
stain
neutral
titer
defin
reciproc
highest
serum
dilut
show
reduct
plaqu
number
viru
control
well
statist
analysi
perform
mannwhitney
test
four
specificpathogenfre
spf
beagl
puppi
detect
antibodi
divid
two
group
mockinfect
vero
cell
cultur
fluid
puppi
viru
puppi
oral
administ
group
total
viru
infect
administ
per
puppi
pfu
puppi
pass
observ
period
without
clinic
abnorm
howev
produc
high
titer
neutral
antibodi
inoculum
fig
hand
titer
osp
less
sera
sampl
point
sampl
examin
condit
supplement
reaction
mixtur
complement
fig
titer
compar
titer
determin
without
complement
obviou
differ
titer
osp
control
puppi
remain
healthi
throughout
studi
neutral
antibodi
respons
either
osp
detect
sera
fig
howev
reaction
mixtur
supplement
complement
replic
virus
lower
serum
dilut
inhibit
fig
twelv
spf
beagl
puppi
immun
two
time
week
apart
commerci
canin
vaccin
product
duramun
max
fort
dodg
anim
health
fort
dodg
kan
vaccin
mlv
product
contain
osp
togeth
canin
parvoviru
type
canin
adenoviru
type
canin
parainfluenza
viru
shown
tabl
antibodi
titer
seem
compar
homolog
osp
howev
statist
shown
significantli
differ
p
examin
complement
supplement
prnt
antibodi
titer
increas
osp
also
result
titer
strain
significantli
differ
p
one
new
cdv
strain
examin
comparison
vaccin
strain
osp
present
studi
follow
reason
two
h
gene
genotyp
japan
ii
cdv
includ
belong
former
epidemiolog
predomin
type
iii
cultiv
strain
avail
genotyp
thu
worthwhil
confirm
present
complementmedi
neutral
use
strain
belong
separ
genotyp
foreign
origin
gener
sever
mechan
antibodi
andor
complement
system
may
mediat
viral
neutral
identifi
elsewher
although
exact
mechan
resist
cdv
fulli
studi
yet
complementmedi
viral
lysi
probabl
account
spons
cdv
observ
vitro
respons
probabl
envelop
virus
coronaviru
orthomyxoviru
arenaviru
retroviru
paramyxoviru
alphaviru
conclus
demonstr
first
time
antibodyand
complementmedi
viru
neutral
cdv
dog
serum
neutral
assay
without
complement
distinguish
two
cdv
strain
antigen
regard
biolog
valuabl
method
assay
complement
hand
observ
differ
neutral
antigen
differ
cdv
strain
disappear
complement
includ
neutral
reaction
mixtur
may
one
immun
mechan
explain
present
canin
distemp
vaccin
use
old
cdv
strain
still
function
suffici
protect
dog
present
genet
vari
field
strain
cdv
thank
frank
roerink
michiru
hashimoto
critic
review
manuscript
assist
prepar
figur
respect
neutral
antibodi
respons
spf
beagl
puppi
oral
inocul
field
cdv
strain
puppi
control
anim
receiv
mockinfect
vero
cell
cultur
fluid
puppi
challeng
viru
antibodi
titer
test
osp
strain
prnt
guinea
pig
complement
without
complement
b
sinc
antibodi
titer
record
control
puppi
reaction
mixtur
supplement
complement
prnt
data
puppi
plot
panel
b
pid
postinocul
day
